Drug intelligence / Profile preview

Sante Beauteye Contact

Development stage
Unknown
Lead developer
Santen Pharmaceutical
Modality
Small Molecules
Administration
Ophthalmic
01

Overview

**Sante Beauteye Contact** is an over-the-counter ophthalmic combination eye drop product developed and manufactured by Santen Pharmaceutical for use while wearing contact lenses. It is a multi-ingredient small-molecule formulation containing pyridoxine hydrochloride, cyanocobalamin, and neostigmine methyl sulfate, intended to relieve eye fatigue, discomfort, bleary vision, and related symptoms associated with soft or hard contact lens wear, and to help prevent minor eye disease. Its pharmacologic rationale is supportive and symptomatic: vitamin B6 and vitamin B12 are included to support ocular tissue metabolism and turnover, while neostigmine methyl sulfate, an acetylcholinesterase inhibitor, is intended to improve ciliary muscle function and reduce accommodative eye fatigue. The product is supplied as ophthalmic eye drops in a 12 mL bottle and is used with most contact lens types except color contact lenses.

Brand names
Sante Beauteye Contact
02

Targets

Acetylcholinesterase

Beyond the preview

Go deeper on Sante Beauteye Contact.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Sante Beauteye Contact.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call